{
    "nctId": "NCT04116151",
    "briefTitle": "Effectiveness of a Cream for Treatment of Dermatitis in Patients Whith Breast Cancer",
    "officialTitle": "Effectivenes and Safety of a Cream of Aloe Vera, Camomila and Tomillo (Alantel) for Profilaxis or Treatmment of Deratitis by Radiotheraphy in Patients With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "DERMATITIS INDUCED BY RADIOTHERAPY IN PATIENTS WHITH BREAST CANCER",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 78,
    "primaryOutcomeMeasure": "Incidence of radiation-induced dermatitis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients 14 years of age or older\n* Diagnosed with cancer and who are or have recently received radiotherapy treatment.\n* We will include patients without dermatitis or with acute dermal posttradiotherapy lesions, in grades 1 and 2.\n\nExclusion Criteria:\n\n* Patients with dermal lesions in grade greater than 2.\n* Skin cancer invasion or distant tumor metastasis.\n* Concurrent chemotherapy with RT, severe / extensive burns, moisture, erosion or suppuration in the skin, history of connective tissue disorders, severe mental disorder (dementia, drug addiction, etc.).\n* History of hypersensitivity reaction to any of the ingredients of the studio cream.\n* Participants involved in other clinical trials within that month.",
    "sex": "ALL",
    "minimumAge": "14 Years",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}